Multiple Myeloma and Alkaline Phosphatase

Kaynakça (5)

1. Çetin G, Eşkazan AE, Ar MC, Aydın ŞÖ, Ferhanoğlu B, Soysal T, Başlar Z, Aydın Y. Bone-specific alkaline phosphatase levels among patients with multiple myeloma receiving various therapy options. Turk J Hematol 2014;31:374-380
2. Li-Fern H, Rajasoorya C. The elevated serum alkaline phosphatase--the chase that led to two endocrinopathies and one possible unifying diagnosis. Eur J Endocrinol 1999;140:143-147
3. Gennari L, Di Stefano M, Merlotti D, Giordano N, Martini G, Tamone C, Zatteri R, De Lucchi R, Baldi C, Vattimo A, Capoccia S, Burroni L, Geraci S, De Paola V, Calabrò A, Avanzati A, Isaia G, Nuti R. Prevalence of Paget’s disease of bone in Italy. J Bone Miner Res 2005;20:1845-1850
4. Badros A, Goloubeva O, Terpos E, Milliron T, Baer MR, Streeten E. Prevalence and significance of vitamin D deficiency in multiple myeloma patients. Br J Haematol 2008;142:492-494
5. Diamond T, Golombick T, Manoharan A. Vitamin D status may affect the skeletal complications of multiple myeloma. Am J Hematol 2010;85:302-303.